© 2021 Smart + Strong. All Rights Reserved. Terms of use and Your privacy. Smart + Strong® is a registered trademark of CDM Publishing, LLC.
A study in mice suggests that therapies approved for breast cancer may also combat other types, including colorectal and stomach cancer.
The FDA is warning that these drugs used to treat advanced breast cancers may cause rare but severe inflammation of the lungs.
At the center of the lawsuit is Teva Pharmaceutical, slated to sell a generic version of the HIV prevention pill PrEP next year.
CDK4/6 inhibitor plus hormone therapy extends progression-free survival for younger women.
CAR-T therapy CTL019 trains immune system to recognize and fight cancer cells.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.
